Product Detail
Sorafenib Tosylate
Sorafenib API
Stock Status: In Stock
Login to view price
Live
For Research & Analytical Purposes. Not for Personal use.
Category
API
API Family
Sorafenib
Storage
Store at refrigerator (2-8°C) for long term storage
Hazard Information
Refer MSDS for accurate information.
Sorafenib Tosylate Product Information
Sorafenib Tosylate is listed under API. It is associated with Sorafenib and is intended for analytical research, quality control and pharmaceutical reference standard applications. The product is supplied by Clearsynth under CAT No. CS-O-31023.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight, stock enquiry details and supporting documentation.
Technical Data
Product Name
Sorafenib Tosylate
CAS No.
475207-59-1
CAT No.
CS-O-31023
Molecular Formula
C28H24ClF3N4O6S
Molecular Weight
637.03
Category
API Family
Storage Condition
Store at refrigerator (2-8°C) for long term storage
SMILES
O=C(C1=NC=CC(OC2=CC=C(NC(NC3=CC=C(Cl)C(C(F)(F)F)=C3)=O)C=C2)=C1)NC.O=S(C4=CC=C(C)C=C4)(O)=O
IUPAC Name
4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamamido]phenoxy]-N-methyl-2-pyridinecarboxamide 4-Methylbenzenesulfonate
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Description
Overview
"Sorafenib tosylate;Sorafenib & its intermediates;Sorafinib mesylate;4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate;Sorafenib Tosylate(Bay 43-9006,Nexavar);"
Synonyms
4-[4-[3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido]phenoxy]-N-methylpicolinamide 4-Methylbenzenesulfonate
Application Notes
"Sorafenib tosylate;Sorafenib & its intermediates;Sorafinib mesylate;4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate;Sorafenib Tosylate(Bay 43-9006,Nexavar);"
References
"Richly; H,; et al,: Int, J, Clin, Pharmacol, Ther,; 41; 620 (2003); Khire; U,R,; et al,: Bioorg, Med, Chem, Lett,; 14; 783 (2004); Wilhelm; S,M,; et al,: Cancer Res,; 64; 7099 (2004); Rini; B,I,; et al,: Expert Opin, Pharmacother,; 7; 453 (2006);"
